Toggle navigation
Home
Search
Services
Blog
Contact
About
New Approaches to Cancer Diagnosis and Treatment
Xu, Yong-Hua
C.P.Li Biomedical Research Corporation, Arlington, VA, United States
Search 3 grants from Yong-Hua Xu
Search grants from C.P.Li Biomedical Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular Mechanisms of AgRP Signaling
Characterization of Genetic Abnormalities in MDS and Their Clinical Impact
The role of Nectins in fusion of the midface and genesis of cleft lip and palate.
ErbB Activation via a Metalloprotease by Angiotensin II
Human Heterotopic Bone Factor
Recently added grants:
Small molecules for expansion of islet beta-cell mass in diabetes
Mitochondrial Dynamics in RPE Homeostasis and Disease
Development of a microphysiologic system to assay the interaction of the human colonic epithelium on Clostridium difficile
The Role of ARAP1 in Retinal Photoreceptor Homeostasis
Evolutionary Human Genomics: Demography, Natural Selection, and Transcriptional Regulation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44CA061619-03
Application #
2102356
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1995-01-05
Project End
1996-11-19
Budget Start
1996-01-01
Budget End
1996-11-19
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
C.P.Li Biomedical Research Corporation
Department
Type
DUNS #
City
Arlington
State
VA
Country
United States
Zip Code
22201
Related projects
NIH 1996
R44 CA
New Approaches to Cancer Diagnosis and Treatment
Xu, Yong-Hua / C.P.Li Biomedical Research Corporation
NIH 1995
R44 CA
New Approaches to Cancer Diagnosis and Treatment
Xu, Yong-Hua / C.P.Li Biomedical Research Corporation
Comments
Be the first to comment on Yong-Hua Xu's grant